US 12180479
Compounds and methods for modulating ATXN1
granted A61KA61K31/712A61K35/30
Quick answer
US patent 12180479 (Compounds and methods for modulating ATXN1) held by Ionis Pharmaceuticals, Inc. expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Dec 31 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 30
- CPC classes
- A61K, A61K31/712, A61K35/30, A61K47/02, A61P